People: MAKO Surgical Corp (MAKO.O)
MAKO.O on Nasdaq
11.53USD
20 May 2013
11.53USD
20 May 2013
Price Change (% chg)
$0.39 (+3.50%)
$0.39 (+3.50%)
Prev Close
$11.14
$11.14
Open
$11.07
$11.07
Day's High
$11.72
$11.72
Day's Low
$11.07
$11.07
Volume
952,114
952,114
Avg. Vol
1,073,964
1,073,964
52-wk High
$27.18
$27.18
52-wk Low
$10.00
$10.00
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Maurice Ferre |
51 | 2004 | Chairman of the Board, President, Chief Executive Officer |
Fritz LaPorte |
42 | 2008 | Chief Financial Officer, Senior Vice President - Finance and Administration, Treasurer |
Menashe Frank |
45 | Senior Vice President, General Counsel, Secretary | |
Christopher Marrus |
46 | 2013 | Senior Vice President - Sales |
Ivan Delevic |
46 | 2012 | Senior Vice President - Marketing |
Lawrence Gibbons |
60 | 2012 | Senior Vice President - Regulatory Affairs and Quality Assurance |
Richard Leparmentier |
44 | 2010 | Senior Vice President - Engineering |
Duncan Moffat |
51 | 2008 | Senior Vice President - Operations |
Charles Federico |
63 | 2009 | Lead Independent Director |
S. Morry Blumenfeld |
74 | 2005 | Independent Director |
Christopher Dewey |
67 | 2004 | Independent Director |
John Freund |
58 | 2008 | Independent Director |
Frederic Moll |
60 | 2007 | Independent Director |
Richard Pettingill |
64 | 2010 | Independent Director |
William Pruitt |
72 | 2008 | Independent Director |
Biographies
| Name | Description |
|---|---|
Maurice Ferre |
Dr. Maurice R. Ferre, M.D., is Chairman of the Board, President, Chief Executive Officer of MAKO Surgical Corp. since November 2004. In May 2004, Dr. Ferré became Chief Executive Officer of Z-KAT, Inc., a surgical navigation medical device company that incorporated MAKO Surgical Corp. Dr. Ferré served as Vice President of Strategic Development at GE Navigation, a division of GE Healthcare, from April 2002 until April 2004. In 1993, Dr. Ferré founded Visualization Technology, Inc., a medical device company for image-guided surgery, and served as its Chief Executive Officer until the company was acquired by GE Healthcare in April 2002. Dr. Ferré holds a B.A. in biology from Bennington College and a Masters in Public Health and an M.D. from Boston University. |
Fritz LaPorte |
Mr. Fritz L. LaPorte is Chief Financial Officer, Senior Vice President - Finance and Administration, Treasurer of MAKO Surgical Corp. From 2001 to November 2004, Mr. LaPorte served as Chief Financial Officer of Z-KAT, Inc. From 1997 to 2000, Mr. LaPorte served as the Director of Finance for Holy Cross Hospital, Inc., a 580-bed acute care facility in Fort Lauderdale, Florida. From 1993 to 1997, Mr. LaPorte served as a Senior Auditor in the Assurance Healthcare Group of Ernst & Young LLP, independent registered public accounting firm. Mr. LaPorte holds a B.B.A. in accounting from Florida Atlantic University and is a Certified Public Accountant. |
Menashe Frank |
Mr. Menashe R. Frank serves as Senior Vice President, General Counsel, Secretary of MAKO Surgical Corp. From July 2004 to November 2004, Mr. Frank was a legal consultant to Z-KAT, Inc. Mr. Frank specialized in corporate transactions and governance as an attorney with the law firm of Hogan & Hartson (now Hogan Lovells) from 2001 to June 2004, and the law firm of Baker & McKenzie from 2000 to 2001. Mr. Frank served as Chief Legal Officer for Enticent.com, Inc. from 1998 to 2000 and was an associate in the business finance and restructuring department of the law firm of Weil, Gotshal & Manges LLP from 1996 to 1998. Mr. Frank holds a B.A. in political science from American University and a J.D. from the University of Miami School of Law. |
Christopher Marrus |
Mr. Christopher R. Marrus has been appointed as Senior Vice President - Sales of MAKO Surgical Corp. He has been with MAKO since February 2012, most recently as MAKO's Senior Director of Sales, East. Previously he served as MAKO's Regional Sales Manager for RIO Sales, East, from February 2012 to January 2013. Mr. Marrus has worked in medical device sales for over fifteen years while managing both capital and procedural sales, national accounts and clinical training. From July 2010 to December 2011, he served as the Vice President of U.S. Sales for EndoGastric Solutions, Inc., a medical device company that develops surgical devices for reconstructive gastrointestinal procedures via a transoral approach, where he was responsible for domestic sales and clinical training. From 2004 to 2010, Mr. Marrus held various positions with Intuitive Surgical, Inc., a surgical robotic company, including Area Vice President, where he managed a portion of the company's national sales team and his responsibilities included both capital and procedural sales. Mr. Marrus holds a B.A. in History from Louisiana State University, and a J.D. from Tulane University. |
Ivan Delevic |
Mr. Ivan Delevic has been appointed as Senior Vice President - Marketing of MAKO Surgical Corp., effective July 17, 2012. He served as Senior Vice President - Strategic Marketing and Business Development of the Company. Beginning in 2007 through April 2009, Mr. Delevic was a business development consultant to medical device companies through ATID Group Inc. and IDAT LLC, companies he founded in 2007. From 1996 to 2007, Mr. Delevic held various positions with General Electric’s healthcare division, both domestically and internationally, including as General Manager for Molecular Imaging EMEA, Global Marketing and Sales Manager for Surgical Navigation, Business Development Manager with GE Healthcare’s Global Business Development, Six Sigma Leader & Black Belt for Global Functional Imaging, and Sales Manager for Southeastern Europe. From 1992 to 1996, Mr. Delevic worked for Johnson & Johnson, Inc. as a Business Manager in Budapest, Hungary. Mr. Delevic holds a M.B.A. from the Technical University of Budapest through a joint program with Herriot-Watt University and a M.S. in Electrical Engineering from the Technical University of Budapest. |
Lawrence Gibbons |
Mr. Lawrence T. Gibbons is Senior Vice President - Regulatory Affairs and Quality Assurance of MAKO Surgical Corp. since February 2012. Prior to accepting his current position at the company, Mr. Gibbons provided the company with consulting services through his former consulting firm, Quality Systems Consulting Services. From 2007 to 2011, Mr. Gibbons held various positions with Fisher & Paykel Healthcare, a medical device manufacturer, including Managing Director, Mexico and Special Consultant to CEO, and was responsible for establishing a manufacturing facility in Mexico and establishing the quality system at the company’s New Zealand headquarters and manufacturing site. From 2006 to 2007, Mr. Gibbons served as Vice President of Quality/Regulatory, Atrial Fibrillation Division, of St. Jude Medical, a medical technology and services company. From 2004 to 2006, Mr. Gibbons served as Vice President of Quality Assurance of Baxter International, Inc., a global healthcare company, where he was responsible for the quality function and overseeing the implementation of the company´s various quality programs. Prior to joining Baxter, Mr. Gibbons was vice president of quality assurance and regulatory affairs for Tyco Healthcare. Mr. Gibbons spent more than 20 years in various quality and regulatory positions with increasing responsibility at Kendall Company, which was acquired by Tyco Healthcare in 1994. Prior to joining Kendall Company, Mr. Gibbons was an investigator with the U.S. Food and Drug Administration´s Boston District Office. Mr. Gibbons currently serves on the board of directors and all of the committees of Fisher and Paykel Healthcare. Mr. Gibbons holds a B.S. in science from the University of Massachusetts. |
Richard Leparmentier |
Mr. Richard Leparmentier is Senior Vice President - Engineering of MAKO Surgical Corp. since March 2010. From 2007 to 2010, Mr. Leparmentier served as U.S. VP of Design and Engineering for ASML, a Dutch lithography equipment company, where he managed a team of approximately 320 engineers across the U.S. and the Netherlands. From 1995 to 2006, Mr. Leparmentier held various positions with GE Healthcare, including Vice President of OEC-Surgery Engineering, in surgical x-ray and navigation equipment, where he managed approximately 270 engineers and his responsibilities included new product development through both internal development and business development, Engineering Manager for radiography products in China, and Lead System Designer for radiographic products in Buc, France. Mr. Leparmentier holds an engineering degree in Biology and Micromechanics from Ecole Polytechnique in France, an engineering degree from Ecole Nationale Supérieure des Télécommunications in France, and an M.B.A. from NYU Stern School of Management. |
Duncan Moffat |
Mr. Duncan H. Moffat is Senior Vice President - Operations of MAKO Surgical Corp. since April 2008. From 2001 to 2008, Mr. Moffat served as Vice President of Operations for the nuclear medicine business of Philips Medical Systems, a worldwide manufacturer of medical imaging equipment. From 1998 to 2001, Mr. Moffat served as Vice President of Operations for Lumisys, a start-up company providing digital x-ray products that was sold to Eastman Kodak in 2001. Beginning in 1982, Mr. Moffat held various positions with the Lucas companies, first with two Lucas affiliates in England, followed by a position as project manager with Lucas Control Systems Products, Hampton, Virginia, and then by a position as Director of Operations with Lucas Deeco Systems, Hayward, California, from 1995 to 1998. Mr. Moffat holds a Bachelor of Science in Electrical and Electronic Engineering, Strathclyde University, Glasgow, Scotland. |
Charles Federico |
Mr. Charles W. Federico is the Lead Independent Director of MAKO Surgical Corp. He has served as one of directors since June 2007. From 2001 to April 2006, Mr. Federico served as President and Chief Executive Officer of Orthofix International N.V., a global diversified medical device company, and, from 1996 to 2001, President of Orthofix Inc. From 1985 to 1996, Mr. Federico was President of Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, Mr. Federico served as Vice President of Dyonics. Previously, he held management and marketing positions with General Foods Corporation, Puritan Bennett Corporation and LSE Corporation. Mr. Federico is a Trustee of the Orthopedic Research and Education Foundation and was a corporate governance panel member at the 2009 Florida Directors Institute. Mr. Federico is chairman of the board and a member of the nominating and corporate governance and compensation committees of SRI/Surgical Express, Inc., and a director, chairman of the compensation committee, and member of the audit committee of BioMimetic Therapeutics, Inc. Mr. Federico previously served as the lead director and a member of the compensation and audit committees of Power Medical Interventions, Inc., as a director of Alveolus, Inc., and as a director of Orthofix International N.V. Mr. Federico holds a B.S. in marketing from Fordham University. |
S. Morry Blumenfeld |
Dr. S. Morry Blumenfeld, Ph.D. is an Independent Director of Mako Surgical Corp since July 2005. In 2003, Dr. Blumenfeld founded Meditech Advisors LLC and Meditech Advisors Management LLC, a member of Ziegler MediTech Partners, LLC, the sole general partner of Ziegler Meditech Equity Partners, LP, a private equity fund specializing in investments in healthcare and medical device companies. In April 2002, Dr. Blumenfeld retired as Managing Director of GE Medical Systems in Israel after more than thirty-four years with the company, where he helped initiate both GE’s CT and MR business lines. Currently, he serves on the Board of Directors of a number of medical device and technology companies, including Oridion Systems Ltd., where he is a member of the compensation committee, Itamar Medical, Aposense LTD, and several private companies. Dr. Blumenfeld holds a B.A.Sc in engineering physics and a Ph.D. in molecular physics from the University of Toronto. |
Christopher Dewey |
Mr. Christopher C. Dewey is Independent Director of MAKO Surgical Corp. since November 2004. From January 2007 to April 2011, Mr. Dewey served as Vice Chairman of the board of directors of National Holdings Corporation, a financial services organization operating through its subsidiary, National Securities. From December 2006 to December 2008, Mr. Dewey served as acting Chief Executive Officer and director of Z-KAT, Inc., a surgical navigation medical device company that incorporated MAKO Surgical Corp. Mr. Dewey has over twenty-five years of experience in finance, most recently as Executive Vice President of Jefferies & Company, Inc., the principal operating subsidiary of Jeffries Group, Inc., a securities and investment banking firm, from 1994 to December 2006. Mr. Dewey co-founded several companies, including Robotic Ventures LLC, Bonds Direct Securities LLC and Cannon Group Inc., a motion picture company that went public in 1972. Mr. Dewey currently serves on the board of Orthosensor, Inc., a medical device company. Mr. Dewey holds an M.B.A. from The Wharton School of the University of Pennsylvania. |
John Freund |
Dr. John G. Freund, M.D. is an Independent Director of Mako Surgical Corp since October 2008. Since 1997, Dr. Freund has been a Managing Director of Skyline Ventures, a venture capital firm. From September 1995 to September 1997, Dr. Freund was a Managing Director in the Alternative Assets Group at Chancellor Capital Management, an investment firm. In 1995, Dr. Freund co-founded Intuitive Surgical, Inc., a medical device company, and served on Intuitive's board of directors until March 2000. From June 1988 to December 1994, Dr. Freund held various positions at Acuson Corporation, a medical device company, including Executive Vice President. From 1982 to 1988, Dr. Freund was at Morgan Stanley & Co., Inc., an investment banking firm, where he was the co-founder of the Healthcare Group in the Corporate Finance Department and later was the original healthcare partner at Morgan Stanley Venture Partners, a venture capital firm affiliated with Morgan Stanley. Dr. Freund is currently the lead outside director and a member of the audit committee and the nominating and corporate governance committee of XenoPort Inc., a biotech company, a director and member of the contracts and governance committee and the nominating committee of the SmallCap World Fund, and a director and member of the contracts committee and the nominating and governance committee of each of The Growth Fund of America, Inc. and Fundamental Investors, Inc., each of which are U.S.-registered investment funds. Dr. Freund also is a director of a number of private companies. Dr. Freund served on the board of directors of Hansen Medical, Inc., a medical device company, from November 2002 to March 2010 and on the board of directors of MAP Pharmaceuticals Inc., a biotech company, from August 2004 until October 2011. Dr. Freund received an M.D. from Harvard Medical School in 1980 and an M.B.A. from Harvard Business School in 1982, where he was a Baker Scholar. |
Frederic Moll |
Dr. Frederic H. Moll, M.D. is an Independent Director of MAKO Surgical Corp since August 2007. Dr. Moll co-founded Hansen Medical, Inc., a medical robotics company, in September 2002, served as its Chief Executive Officer through June 2010, and currently serves on its board of directors. In November 1995, Dr. Moll co-founded Intuitive Surgical, Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director until September 2003. In 1989, Dr. Moll co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, a medical device company, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant’s surgical device division until November 1995. Dr. Moll holds a B.A. from the University of California, Berkeley, an M.S. from Stanford University and an M.D. from the University of Washington School of Medicine. |
Richard Pettingill |
Mr. Richard R. Pettingill is Independent Director of MAKO Surgical Corp., since August 2010. Mr. Pettingill served as the President and Chief Executive Officer of Allina Hospitals and Clinics, Minnesota’s healthcare organization, from 2002 until his retirement in 2009. While in this role, he also served on the board of directors of the Minnesota Hospital Association and the Minnesota Business Partnership. Prior to joining Allina Hospitals and Clinics, Mr. Pettingill served as Executive Vice President and Chief Operating Officer of Kaiser Foundation Health Plans and Hospitals from 1996 to 2002. From 1991 to 1995, he served as President and Chief Executive Officer of Camino Healthcare, a community based integrated delivery system. Mr. Pettingill is a director and member of the health IT standards, compensation and quality, compliance and ethics committees of Tenet Healthcare Corporation. Mr. Pettingill received a bachelor’s degree from San Diego State University and a master’s degree in health care administration from San Jose State University. He served as a 2010 Fellow in the Advanced Leadership Initiative program at Harvard University. |
William Pruitt |
Mr. William D. Pruitt serves as an Independent Director of MAKO Surgical Corp since June 2008. Mr. Pruitt is president of Pruitt Enterprises, LP, a business and accounting consulting firm. Mr. Pruitt is currently a director, chairman of the audit committee, and a member of the compensation committee of Swisher Hygiene, Inc., a provider of hygiene products, a director and chairman of the audit committee of Coral Gables Trust Company, a wealth management, trust and estate services firm, a director of Auxis, Inc., a management consulting and outsourcing firm, a director of Greensmith Energy Management Systems, an energy storage company, and a director and a member of the audit committee of NV5, Inc., a private engineering company. Mr. Pruitt served as chairman of the audit committee and a member of the compensation committee of The PBSJ Corporation, an international professional services firm, until its sale in 2010 and chairman of the audit committee of Kos Pharmaceuticals, Inc., a fully integrated specialty pharmaceutical company, until its sale in 2006. He also was chairman of the audit committee for Adjoined Consulting, Inc., a full-service management consulting firm, until it was merged into Kanbay International, a global consulting firm, in February 2006. From 2002 to 2004, Mr. Pruitt provided market consultancy services to Ernst & Young LLP, independent registered public accounting firm. From 1980 to 1999, Mr. Pruitt served as the managing partner for the Florida, Caribbean and Venezuela operations of the independent auditing firm of Arthur Andersen LLP. Mr. Pruitt holds a Bachelor of Business Administration from the University of Miami and is a Certified Public Accountant (inactive). |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Maurice Ferre |
4,218,870 |
Fritz LaPorte |
939,041 |
Menashe Frank |
812,813 |
Christopher Marrus |
-- |
Ivan Delevic |
896,165 |
Lawrence Gibbons |
-- |
Richard Leparmentier |
907,828 |
Duncan Moffat |
431,709 |
Charles Federico |
-- |
S. Morry Blumenfeld |
-- |
Christopher Dewey |
-- |
John Freund |
-- |
Frederic Moll |
-- |
Richard Pettingill |
-- |
William Pruitt |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Maurice Ferre |
38,745 | 696,730 |
Fritz LaPorte |
112,466 | 2,671,380 |
Menashe Frank |
114,140 | 3,145,980 |
Christopher Marrus |
0 | 0 |
Ivan Delevic |
22,500 | 639,234 |
Lawrence Gibbons |
0 | 0 |
Richard Leparmentier |
0 | 0 |
Duncan Moffat |
0 | 0 |
Charles Federico |
0 | 0 |
S. Morry Blumenfeld |
0 | 0 |
Christopher Dewey |
0 | 0 |
John Freund |
0 | 0 |
Frederic Moll |
0 | 0 |
Richard Pettingill |
0 | 0 |
William Pruitt |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
FERRE MAURICE R |
2,622 | $10.65 |
FERRE MAURICE R |
2,622 | $11.27 |
FERRE MAURICE R |
2,622 | $11.03 |
FERRE MAURICE R |
2,278 | $13.95 |
PRUITT WILLIAM D |
10,000 | $13.45 |
DEWEY CHRISTOPHER C |
25,000 | $13.15 |
DEWEY CHRISTOPHER C |
9,771 | $15.71 |
DEWEY CHRISTOPHER C |
51,182 | $3.00 |
FERRE MAURICE R |
5,631 | $3.00 |
FERRE MAURICE R |
1,075 | $15.71 |
PETTINGILL RICHARD R |
7,775 | $12.93 |
FEDERICO CHARLES W |
2,000 | $12.95 |
MOFFAT DUNCAN H |
6,798 | $25.77 |
MOFFAT DUNCAN H |
22,064 | $7.94 |
PRUITT WILLIAM D |
2,000 | $23.19 |
PRUITT WILLIAM D |
1,000 | $23.67 |
PRUITT WILLIAM D |
2,000 | $23.68 |
MOLL FREDERIC H |
5,000 | $24.15 |
DEWEY CHRISTOPHER C |
44,224 | $24.18 |
DEWEY CHRISTOPHER C |
60,000 | $3.00 |
DEWEY CHRISTOPHER C |
4,382 | $41.08 |
SAVARESE JOHN |
718,455 | $24.68 |
DEWEY CHRISTOPHER C |
21,500 | $24.99 |
SAVARESE JOHN |
82,253 | $25.48 |
SAVARESE JOHN |
437,542 | $26.06 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
